5C1Y | pdb_00005c1y

Crystal structure of EV71 3C Proteinase in complex with Compound 1


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.97 Å
  • R-Value Free: 
    0.290 (Depositor), 0.292 (DCC) 
  • R-Value Work: 
    0.211 (Depositor), 0.217 (DCC) 
  • R-Value Observed: 
    0.214 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 5C1Y

Ligand Structure Quality Assessment 


This is version 2.2 of the entry. See complete history

Literature

Optimize the interactions at S4 with efficient inhibitors targeting 3C proteinase from enterovirus 71

Zhang, L.Huang, G.Cai, Q.Zhao, C.Tang, L.Ren, H.Li, P.Li, N.Huang, J.Chen, X.Guan, Y.You, H.Chen, S.Li, J.Lin, T.

(2016) J Mol Recognit 29: 520-527

  • DOI: https://doi.org/10.1002/jmr.2551
  • Primary Citation Related Structures: 
    5C1U, 5C1X, 5C1Y, 5C20

  • PubMed Abstract: 

    Enterovirus 71 (EV71) is the causative agent of hand, foot and mouth disease and can spread its infections to the central nervous and other systems with severe consequences. The replication of EV71 depends on its 3C proteinase (3C pro ), a significant drug target. By X-ray crystallography and functional assays, the interactions between inhibitors and EV71 3C pro were evaluated. It was shown that improved interactions at S4 for the substrate binding could significantly enhance the potency. A new series of potent inhibitors with high ligand efficiency was generated for developing antivirals to treat and control the EV71-associated diseases. Copyright © 2016 John Wiley & Sons, Ltd.


  • Organizational Affiliation
    • State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, State-Province Joint Engineering Laboratory of Targeted Drugs from Natural Products, School of Life Sciences, Xiamen University, Xiamen, Fujian, China.

Macromolecule Content 

  • Total Structure Weight: 21.78 kDa 
  • Atom Count: 1,486 
  • Modeled Residue Count: 181 
  • Deposited Residue Count: 192 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
3C proteinase192Enterovirus A71Mutation(s): 0 
EC: 3.4.22.28
UniProt
Find proteins for A9XG43 (Human enterovirus 71)
Explore A9XG43 
Go to UniProtKB:  A9XG43
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupA9XG43
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 1 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
GHY

Query on GHY



Download:Ideal Coordinates CCD File
B [auth A]propan-2-yl N-[(2S)-1-oxidanylidene-1-[[(2S)-1-oxidanyl-3-[(3S)-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-3-phenyl-propan-2-yl]carbamate
C20 H29 N3 O5
DESRATCONZEYFJ-ULQDDVLXSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.97 Å
  • R-Value Free:  0.290 (Depositor), 0.292 (DCC) 
  • R-Value Work:  0.211 (Depositor), 0.217 (DCC) 
  • R-Value Observed: 0.214 (Depositor) 
Space Group: C 2 2 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 64.367α = 90
b = 65.062β = 90
c = 75.862γ = 90
Software Package:
Software NamePurpose
HKL-2000data reduction
HKL-2000data scaling
PHASERphasing
REFMACrefinement

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2016-06-01
    Type: Initial release
  • Version 1.1: 2016-10-26
    Changes: Database references
  • Version 2.0: 2020-09-02
    Changes: Derived calculations, Non-polymer description, Structure summary
  • Version 2.1: 2023-11-08
    Changes: Data collection, Database references, Refinement description
  • Version 2.2: 2024-11-06
    Changes: Structure summary